CAGNACCI, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 14.431
AS - Asia 4.210
EU - Europa 2.816
SA - Sud America 579
Continente sconosciuto - Info sul continente non disponibili 572
AF - Africa 56
OC - Oceania 6
Totale 22.670
Nazione #
US - Stati Uniti d'America 14.302
SG - Singapore 2.085
CN - Cina 844
UA - Ucraina 761
HK - Hong Kong 456
BR - Brasile 450
DE - Germania 393
SE - Svezia 354
IT - Italia 334
TR - Turchia 249
RU - Federazione Russa 239
VN - Vietnam 226
FR - Francia 189
IE - Irlanda 160
FI - Finlandia 115
GB - Regno Unito 102
IN - India 76
BD - Bangladesh 63
CA - Canada 59
AR - Argentina 33
MX - Messico 33
IQ - Iraq 32
JP - Giappone 30
VE - Venezuela 27
NL - Olanda 26
CO - Colombia 25
EC - Ecuador 23
PL - Polonia 22
EU - Europa 20
KR - Corea 19
AT - Austria 18
BE - Belgio 17
ES - Italia 17
ID - Indonesia 16
CZ - Repubblica Ceca 15
PK - Pakistan 14
RS - Serbia 13
PH - Filippine 12
ZA - Sudafrica 11
SA - Arabia Saudita 10
KE - Kenya 9
JO - Giordania 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
MA - Marocco 7
TT - Trinidad e Tobago 7
EG - Egitto 6
MY - Malesia 6
NP - Nepal 6
UZ - Uzbekistan 6
AU - Australia 5
CR - Costa Rica 5
HN - Honduras 5
IL - Israele 5
TH - Thailandia 5
TN - Tunisia 5
AL - Albania 4
DK - Danimarca 4
ET - Etiopia 4
JM - Giamaica 4
KZ - Kazakistan 4
PS - Palestinian Territory 4
PY - Paraguay 4
RO - Romania 4
AM - Armenia 3
BG - Bulgaria 3
HR - Croazia 3
KG - Kirghizistan 3
MD - Moldavia 3
OM - Oman 3
PE - Perù 3
SV - El Salvador 3
UY - Uruguay 3
AF - Afghanistan, Repubblica islamica di 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
CG - Congo 2
DZ - Algeria 2
GE - Georgia 2
HU - Ungheria 2
IM - Isola di Man 2
IR - Iran 2
LC - Santa Lucia 2
LT - Lituania 2
LV - Lettonia 2
LY - Libia 2
NI - Nicaragua 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TG - Togo 2
AW - Aruba 1
BB - Barbados 1
CD - Congo 1
DO - Repubblica Dominicana 1
Totale 22.098
Città #
Fairfield 1.776
Woodbridge 1.287
Ashburn 1.282
Singapore 1.039
Houston 901
Chandler 848
Seattle 731
Wilmington 636
Cambridge 604
Ann Arbor 572
Hong Kong 450
Beijing 407
Dearborn 395
Jacksonville 361
Boardman 247
Izmir 230
Council Bluffs 215
San Jose 180
Los Angeles 171
Dublin 160
Princeton 156
Dallas 150
Lauterbourg 150
Des Moines 130
New York 103
Santa Clara 101
Milan 82
San Diego 80
Chicago 79
Redondo Beach 65
Buffalo 60
Ho Chi Minh City 60
Dong Ket 45
Falls Church 42
Hanoi 41
Salt Lake City 41
São Paulo 41
Atlanta 37
San Francisco 37
Hefei 35
Phoenix 34
Denver 33
Orem 33
Udine 33
Helsinki 31
Saint Petersburg 30
Frankfurt am Main 29
Norwalk 29
Kunming 28
Ogden 27
The Dalles 27
Tokyo 27
Munich 26
Nanjing 25
Brooklyn 24
Guangzhou 24
Miano 23
Chennai 18
Grafing 17
Philadelphia 17
Brussels 16
Montreal 16
Venezia 16
Warsaw 16
Baghdad 14
Mumbai 14
Tampa 14
Toronto 14
Brno 13
Fuzhou 13
Miami 13
Rome 13
Amsterdam 12
Belgrade 12
Düsseldorf 12
Nuremberg 12
Sterling 12
Curitiba 11
Detroit 11
Guayaquil 11
Jinan 11
Mexico City 11
Nanchang 11
Poplar 11
Redmond 11
Stockholm 11
Zhengzhou 11
Charlotte 10
Da Nang 10
Rio de Janeiro 10
Elk Grove Village 9
Istanbul 9
Las Vegas 9
Sorocaba 9
Tappahannock 9
Vienna 9
Brasília 8
Chengdu 8
Haiphong 8
Hebei 8
Totale 15.020
Nome #
Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women 653
Female sexuality and vaginal health across the menopausal age 400
Fetal growth at term and placental oxidative stress in a tissue micro-array model: a histological and immunohistochemistry study 347
Atypical polypoid adenomyoma follow-up and management: Systematic review of case reports and series and meta-analysis 315
Regulation of the 24h body temperature rhythm of women in luteal phase: role of gonadal steroids and prostaglandins. 242
Menopausal symptoms and risk factors for cardiovascular disease in postmenopause. 233
Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis 221
Transdermal administration of estradiol and norethisterone: effect on the uterus and uterine arteries 216
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 209
Bleeding profile in users of an etonogestrel sub-dermal implant: Effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population 198
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 195
Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. 194
Association between pelvic organ prolapse and climacteric symptoms in postmenopausal women 193
Association between urinary incontinence and climacteric symptoms in postmenopausal women 186
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. 185
Integrated Clinical Pathways in vaginal and caesarean delivery: effect analysis 2016-2017, Italy 185
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 184
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. 181
Adenomyosis of the Extrapelvic Portion of the Round Ligament 181
Massive Hemoperitoneum from Uterine Leiomyoma Associated with Diffuse Myometrial Venous Congestion 175
Intermenstrual pelvic pain, quality of life and mood 171
Maternal age and the risk of adverse pregnancy outcomes: a retrospective cohort study 169
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. 168
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 166
A comparison of the central effects of different progestins used in hormone replacement therapy 165
Influences of maternal weight on the secondary sex ratio of human offspring 162
Indirect evidence that estrogen replacement therapy stimulates nitric oxide synthase in postmenopausal women 162
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women. 161
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 161
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study. 160
Chronic pelvic pain improvement: impact on quality of life and mood 160
Prevalence of menstrual pain in young women: what is dysmenorrhea 157
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 156
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 155
The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study 155
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 155
Course of primary headaches during hormone replacement therapy 154
Increased cortisol level: a possible link between climacteric symptoms and cardiovascular risk factors. 153
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 153
[Evolution and future of contraception.] 153
Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women 152
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 151
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study. 150
Raloxifene does not influence flow-mediated endothelium-dependent and endothelium-independent vasodilatation of osteopenic postmenopausal women. 149
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 149
Folate administration decreases oxidative status and blood pressure in postmenopausal women 148
Different circulatory response to melatonin in postmenopausal women without and with hormone replacement therapy 148
Role of melatonin in circadian rhythm at menopause 147
Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: a double-blind, placebo-controlled study. 144
Dienogest mediates midkine suppression in endometriosis 144
Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function. 144
Counseling on vaginal delivery of contraceptive hormones: implications for women's body knowledge and sexual health 144
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 142
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women 142
Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women. 142
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 142
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study 141
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 141
Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: role of hormone replacement therapy 141
Acupuncture or phy(F)itoestrogens vs. (E)strogen plus progestin on menopausal symptoms. A randomized study 140
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. 138
Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome 138
Thoracic ultrasound evaluation and B-type natriuretic peptide value in elective cesarean section under spinal anesthesia 138
Raloxifene does not modify insulin sensitivity and glucose metabolism in postmenopausal women. 137
Sexual dimorphism in the levels of amniotic fluid leptin in pregnancies at 16 weeks of gestation 137
Prolonged melatonin administration decreases nocturnal blood pressure in women. 136
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group (.) 136
Hormonal contraception: venous and arterial disease 136
Management of vaginal atrophy: a real mess. Results from the AGATA study 136
Ospemifene in the management of vulvar and vaginal atrophy: Focus on the assessment of patient acceptability and ease of use 136
Metabolic impact of combined hormonal contraceptives containing estradiol 135
Impact of transvaginal hydrolaparoscopy ovarian drilling on ovarian stromal blood flow and ovarian volume in clomiphene citrate-resistant PCOS patients: a case-control study 135
Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: Comparison between oral and transdermal administration of estrogen 134
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis 134
European society of contraception statement on contraception in obese women 134
History of vasomotor symptoms, extent of coronary artery disease, and clinical outcomes after acute coronary syndrome in postmenopausal women 134
Hormone replacement therapy and prevention of chronic conditions 134
Effects of low- or high-dose hormone therapy on fasting and post-methionine homocysteine levels in postmenopausal women 133
Intensity of menstrual pain and estimated angle of uterine flexion 133
Pharmacokinetic evaluation of desogestrel as a female contraceptive 131
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 131
Insulin sensitivity in women: a comparison among values derived from intravenous glucose tolerance tests with different sampling frequency, oral glucose tolerance test or fasting 130
Reply to: Interactions BetweenMelatonin and Estrogen in the Regulation of Blood Pressure 130
Vaginal atrophy across the menopausal age: results from the ANGEL study 130
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 127
Influence of exogenous melatonin on catecholamine levels in postmenopausal women prior and during oestradiol replacement 127
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 127
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 127
ISPOG European Consensus Statement - chronic pelvic pain in women (short version) 127
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: A prospective one-year evaluation 127
Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data 127
Season of birth influences the timing of menopause 126
The male disadvantage and the seasonal rhythm of sex ratio at the time of conception. 126
Is voluntary abortion a seasonal disorder of mood? 126
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 126
Kava-Kava administration reduces anxiety in perimenopausal women. 126
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 125
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 125
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 125
Oral contraceptives and insulin sensitivity 123
Totale 16.233
Categoria #
all - tutte 79.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.493


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.175 0 0 124 93 33 96 98 54 29 210 231 207
2022/20231.930 181 104 19 256 211 587 6 140 276 24 63 63
2023/2024426 113 55 12 10 66 50 7 39 37 9 10 18
2024/20252.426 49 198 231 96 124 147 128 193 345 164 188 563
2025/20264.659 279 733 323 253 729 403 694 131 189 297 240 388
2026/20271.716 626 778 312 0 0 0 0 0 0 0 0 0
Totale 22.670